Annual Congress Amsterdam 2011

Saturday, 24.09.2011
Sunday, 25.09.2011
Monday, 26.09.2011
Tuesday, 27.09.2011
Wednesday, 28.09.2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

4205 Abstracts
632 Slide presentations
250 Webcasts
66 Handouts
1703 e-posters
250 Multimedia files

Material from 2011 Show

Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis

Poster Discussion
Chairs: G. Guenther (Borstel, Germany), V. Botnaru (Chisinau, Republic of Moldova)

Download all media

Temporal trend analysis of TB treatment outcomes in the WHO European region M. Dara, G. Sotgiu, A. Dadu, H. Kluge, M. Grzemska, R. Centis, L. D‘Ambrosio, G. B. Migliori (Copenhagen, Denmark; Tradate, Sassari, Italy; Geneva, Switzerland)
Predictors of treatment outcome in multidrug-resistant tuberculosis O. Oliveira, M. Villar, R. Duarte (Porto, Lisbon, Vila Nova de Gaia, Portugal)
Risk factors for drug-resistant tuberculosis in the north of Portugal M. Gomes, A. Correia, D. Mendonça, R. Duarte (Vila Nova de Gaia, Porto, Portugal)
Treatment of MDR tuberculosis in Switzerland. A case control study W. Karrer, H. Shang, P. Brun (Crans-Montana, Switzerland)
Gender and other risk factors for multidrug-resistant (MDR) tuberculosis (TB) among migrants to Milan, Italy A. Repossi, M. Delmastro, M. Ferrarese, G. Ferrara, N. Murgia, L. Codecasa (Milan, Terni, Perugia, Italy)
Treatment outcomes of MDR-TB patients notified in Romania during 2005-2007 N. Cioran, E. Ibraim, H. Cocei (Bucharest, Romania)
Why did they get XDR TB ? V. Cojocariu, A. Sorete Arbore, T. Mihaescu (Iasi, Romania)
Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis E. Unsal, M. Guler, R. Ofluoglu, N. Capan (Ankara, Turkey)
Characteristics of XDR-TB patients in Israel: 2000-2010 D. Bendayan, A. Hendler, K. Litman (Beer Yaakov, Israel)
Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors T. Sahasrabudhe, V. Oswal (Pune, India)
Treatment outcome of multi-drug resistant tuberculosis treated as outpatient in a tertiary care center I. Muhammad, A. S. Haque, Z. Waheed, J. A. Khan (Karachi, Pakistan)
Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy R. Prasad, A. Singh, R. A. S. Kushwaha, R. Garg, S. Kumar Verma, S. Saheer, G. Hosmane, R. Srivastava, A. Jain (Lucknow, India)
Recurrence after successful treatment among patients with multidrug-resistant tuberculosis C. G. Yoo, J. Lee, Y. S. Park, S. M. Lee, J. J. Yim, S. C. Yang, Y. W. Kim, Y. S. Shim, S. K. Han (Seoul, Seongnam, Republic Of Korea)
Risk factors for primary multidrug-resistant tuberculosis in Hanoi, Viet Nam N. T. L. Hang, L. T. Lien, N. Kobayashi, P. H. Thuong, N. V. Hung, A. Nanri, T. Mizoue, S. Maeda, T. B. Thuy, N. P. Hoang, S. Sakurada, N. Keicho (Hanoi, Viet Nam; Tokyo, Japan)
The analysis of the reasons of failures in treatment at MDR TB pationts P. Golubchikov, S. Mishustin, N. Zemlyanaya (Tomsk, Russian Federation)
Death rates in patients during and after MDR-TB treatment in a semi rural area of South Africa M. Van der Walt, K. Shean, M. Van Rensburg (Pretoria, Klerskdorp, South Africa)